>>According to court records, colleagues had questions about whether Potts-Kant had even purchased methacoline, a drug she said she used in experiments. Meanwhile, Duke was trying to control the message. A colleague told Thomas at the time that Duke's research integrity office did not want the case to "snowball," and that it wanted to write any retraction notices.
That would suggest there was no way she could have had the data. Even after they knew the data was bad (or probably bad), it was used by others as well was Potts-Kant to secure additional funding. I think the court couldn't definitively say when Duke became aware of the fraud, but I think they had enough reason to be concerned about the integrity of the data that they should have acted more strongly and been more forthright.
https://www.medscape.com/viewarticle/910922?nlid=129046_3902...
This is more akin to medicare fraud, but without criminal penalties.
It seem like the fake research was used to obtain 100s of millions in grants.
"... A former researcher at Duke University has admitted to faking data that allegedly were used to secure hundreds of millions of dollars in federal grants. Duke has also admitted that it knew Erin Potts-Kant, a pulmonary scientist, faked data, but it’s unclear whether that was discovered prior to using those data to apply for grants, .."